HRL
38
3
EXPD
48
-2
DRI
64
4
AEE
58
3
FITB
72
2
FIS
73
11
COP
44
-3
IBM
67
2
SPG
53
2
KMB
33
2
UPS
40
2
HSY
50
5
V
54
2
PX
55
2
ADM
47
2
CNP
55
3
CRM
59
-11
MO
57
4
NWL
57
3
A
46
2
HRL
38
3
EXPD
48
-2
DRI
64
4
AEE
58
3
FITB
72
2
FIS
73
11
COP
44
-3
IBM
67
2
SPG
53
2
KMB
33
2
UPS
40
2
HSY
50
5
V
54
2
PX
55
2
ADM
47
2
CNP
55
3
CRM
59
-11
MO
57
4
NWL
57
3
A
46
2
Financhill
Back

Alzamend Neuro, Inc. 10K Form

Sell
20

ALZN
Alzamend Neuro, Inc.

Last Price:
$2.03
Seasonality Move:
-32.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALZN News And Ratings

See the #1 stock for the next 7 days that we like better than ALZN

ALZN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-1.2M
Price / Cash Flow: 0
Annual Sales: $1.15
Price / Book: 1.46

Profitability

EPS (TTM): -5.49580
Net Income (TTM): $-5.9M
Gross Margin: $-50.7K
Return on Equity: -140.8%
Return on Assets: -116.69%

Alzamend Neuro, Inc. Earnings Forecast

Key Alzamend Neuro, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 3 years.

Alzamend Neuro, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALZN
Website: alzamend.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.58
Quick Ratio: 6.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALZN Technical Analysis vs Fundamental Analysis

Sell
20
Alzamend Neuro, Inc. (ALZN) is a Sell

Is Alzamend Neuro, Inc. a Buy or a Sell?